These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1365354)

  • 1. [Prevention of sudden death using implantable defibrillators].
    Toivonen L; Viitasalo M; Järvinen A; Verkkala K; Nieminen MS; Heikkilä J
    Duodecim; 1991; 107(16):1323-30. PubMed ID: 1365354
    [No Abstract]   [Full Text] [Related]  

  • 2. Implantable defibrillators and sudden cardiac death.
    Josephson M; Wellens HJ
    Circulation; 2004 Jun; 109(22):2685-91. PubMed ID: 15184292
    [No Abstract]   [Full Text] [Related]  

  • 3. [Low energy cardioversion with the implantable cardioversion defibrillator devices for treatment of ventricular tachycardia and ventricular fibrillation].
    Siebels J; Schneider MA; Kuck KH
    Z Kardiol; 1993 Nov; 82(11):683-91. PubMed ID: 8291289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular tachycardia and ventricular fibrillation.
    Srivathsan K; Ng DW; Mookadam F
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):801-9. PubMed ID: 19589116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The automatic implantable cardioverter-defibrillator for prevention of sudden heart death in children and adolescents].
    Paul T; Luhmer I; Trappe HJ; Klein H; Fieguth HG; Brauer C; Scharpwinkel U; Kallfelz HC
    Z Kardiol; 1993 Aug; 82(8):466-73. PubMed ID: 8212779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular fibrillation and life-threatening ventricular tachycardia in the setting of outflow tract arrhythmias--the place of ICD therapy.
    Valk SD; Dabiri-Abkenari L; Theuns DA; Thornton AS; Res JC; Jordaens L
    Int J Cardiol; 2013 May; 165(2):385-7. PubMed ID: 22989608
    [No Abstract]   [Full Text] [Related]  

  • 7. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators.
    Lampert R; McPherson CA; Clancy JF; Caulin-Glaser TL; Rosenfeld LE; Batsford WP
    J Am Coll Cardiol; 2004 Jun; 43(12):2293-9. PubMed ID: 15193696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A; Ghidina M
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract]   [Full Text] [Related]  

  • 10. A comprehensive approach to management of ventricular arrhythmias.
    Kusumoto F
    Cardiol Clin; 2008 Aug; 26(3):481-96, vii. PubMed ID: 18538192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Implantable defibrillators in the management of malignant ventricular tachyarrhythmias. Experience at the Arrhythmia National Center].
    Asenjo R; Oyarzún R; González M; Morales P; Zamorano J; Brunet L; Morris R; Ortiz M
    Rev Med Chil; 1998 Jul; 126(7):803-13. PubMed ID: 9830773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Short-term and long-term outcome of left heart function after cardioverter defibrillator implantation].
    Takeichi K; Kasanuki H; Ohnishi S; Endoh Y; Hosoda S
    J Cardiol; 1996 Nov; 28(5):277-86. PubMed ID: 8953401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of sudden death and the countermeasures--implantable defibrillators].
    Kasanuki H
    Nihon Naika Gakkai Zasshi; 1998 Jan; 87(1):105-16. PubMed ID: 9513555
    [No Abstract]   [Full Text] [Related]  

  • 14. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Automatic implantable defibrillators].
    Licourt J; Orvin MA
    Soins; 2003 Jan; Spec No 1(1):12-5. PubMed ID: 12621698
    [No Abstract]   [Full Text] [Related]  

  • 16. Implantable cardioverter-defibrillator therapy for prevention of sudden cardiac death.
    Akhtar M; Jazayeri MR; Sra JS; Dhala A; Deshpande S; Blanck Z; Axtell K
    Cardiol Clin; 1993 Feb; 11(1):97-108. PubMed ID: 8435827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of implantable cardioverter defibrillators in the secondary prevention of malignant ventricular arrhythmias: lessons from large studies].
    Anadolu Kardiyol Derg; 2001 Mar; 1(1):43-7, AXIV. PubMed ID: 12132492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological impact of microvolt T-wave alternans in sudden cardiac death primary prevention.
    Daccarett M; Serafimovski N; Machado C
    Int J Cardiol; 2007 Jun; 119(1):127-8; author reply 129-30. PubMed ID: 17049385
    [No Abstract]   [Full Text] [Related]  

  • 19. [Implantable cardioverter-defibrillators in the prevention of sudden cardiac death].
    Kozák M; Krivan L; Semrád B
    Vnitr Lek; 2001 Jun; 47(6):361-70. PubMed ID: 11494881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prophylactic ICD? Who are the patients? What is the device?
    Nisam S
    Europace; 2001 Oct; 3(4):269-74. PubMed ID: 11678383
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.